ONWARD Medical
ONWARD Medical is dedicated to creating therapies that restore movement, function, and independence for people with spinal cord injury (SCI). They develop innovative neurostimulation systems, including ARCEX, ARCIM, and ARCBCI, which are investigational or approved for use in specific regions. Their mission is driven by a team of scientists, engineers, and physicians committed to advancing neurotechnology and improving quality of life for individuals with SCI.
Industries
Nr. of Employees
medium (51-250)
ONWARD Medical
Eindhoven, Noord-Brabant, The Netherlands, Europe
Products
External transcutaneous spinal cord stimulation system for upper-limb rehabilitation
A clinic-delivered external transcutaneous spinal cord stimulation system intended to deliver programmed stimulation combined with task practice to improve hand sensation and strength in adults with chronic, incomplete spinal cord injury.
Investigational implantable spinal cord stimulation platform
An implantable neurostimulation system designed to deliver targeted spinal cord stimulation to restore motor function and regulate autonomic functions such as blood pressure; currently investigational with multiple Breakthrough Device designations.
Combined BCI-to-stimulation investigational therapy
A combined investigational therapy that decodes cortical signals via a brain-computer interface and translates intentions into commands to an implantable spinal stimulation system to restore thought-driven movement.
External transcutaneous spinal cord stimulation system for upper-limb rehabilitation
A clinic-delivered external transcutaneous spinal cord stimulation system intended to deliver programmed stimulation combined with task practice to improve hand sensation and strength in adults with chronic, incomplete spinal cord injury.
Investigational implantable spinal cord stimulation platform
An implantable neurostimulation system designed to deliver targeted spinal cord stimulation to restore motor function and regulate autonomic functions such as blood pressure; currently investigational with multiple Breakthrough Device designations.
Combined BCI-to-stimulation investigational therapy
A combined investigational therapy that decodes cortical signals via a brain-computer interface and translates intentions into commands to an implantable spinal stimulation system to restore thought-driven movement.
Services
Clinical trial design and execution
Setup and coordination of multi-center feasibility and pivotal clinical trials for neurostimulation therapies, including endpoint definition, site coordination, and safety monitoring.
Patient registry and recruitment
Maintenance of a patient registry and processes to identify and recruit prospective participants for investigational studies and clinical trials.
Academic and clinical research partnerships
Collaborative research, licensing of academic IP, and participation in multi-institution consortia to develop and clinically evaluate neurotechnology.
Clinical trial design and execution
Setup and coordination of multi-center feasibility and pivotal clinical trials for neurostimulation therapies, including endpoint definition, site coordination, and safety monitoring.
Patient registry and recruitment
Maintenance of a patient registry and processes to identify and recruit prospective participants for investigational studies and clinical trials.
Academic and clinical research partnerships
Collaborative research, licensing of academic IP, and participation in multi-institution consortia to develop and clinically evaluate neurotechnology.
Expertise Areas
- Clinical trial management for neuromodulation
- Neurostimulation and neuromodulation therapies
- Brain-computer interface development
- Neurorehabilitation for spinal cord injury
Key Technologies
- Transcutaneous spinal cord stimulation
- Implantable spinal cord neurostimulation
- Brain-computer interface (BCI)
- AI-driven neural signal decoding